Device Trial Radar · NCT07902167
Evaluating the Efficacy and Safety of a New Laparoscopic Non-mesh Hernia Needle Set Designed for Indirect Inguinal Hernia
Last checked: Nov 19, 2026Latest source record: Oct 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
96
Planned (sponsor's estimate)
Start
Mar 4, 2026
Primary completion
Apr 30, 2027
Study completion Apr 30, 2027
Sponsor
- Lead sponsor
- Chang Gung Memorial HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Oct 28, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a prospective, single-blinded and randomized clinical trial, and will be conducted at Chang Gung Memorial Hospital Chiayi branch in Taiwan. 1. Why is this study being done? Inguinal hernia is a common condition in adults. It can be classified into different types, and more than half of adult inguinal hernias are belonged to the "indirect" type. Traditionally, inguinal hernias are repaired with artificial mesh in adults. Since 2018, we use the laparoscopy-assisted percutaneous internal ring suture (PIRS), which has been proofed to be safe and effectiveness in repairing the pediatric indirect inguinal hernia, to treat the adult indirect inguinal hernias. More than 150 adult patients were treated by using this method with good results and low recurrence rate. However, conventional needles for the pediatric group are too short and weak to operate on the adult group. Now there is a new device, laparoscopic non-mesh hernia needle set, designed specifically for adults. We would like to evaluate whether this new device can: (1) Shorten the operation time; (2) Reduce postoperative pain; (3) Maintain a low recurrence rate 2. What will happen to the participants The participants, whose hernia confirmed to be the indirect type under laparoscopic inspection, would be randomly assigned to one of two groups: (1) The control group: using conventional needle set for PIRS; (2) The experimental group: using laparoscopic non-mesh hernia needle set for PIRS. Both groups would undergo the same surgical method except the needle devices. For the participants with inguinal hernias other than the indirect type, an adequate mesh repair be performed according to the Guideline of Hernia Surg (Hernia. 2018; 22(1): 17-18) After surgery, three follow-up visits within six months would be arranged to all participants. Each visit will take about one hour. During these visits, we will: (1) Record about recovery and pain conditions; (2) Check surgical wound; (3) Evaluate whether the hernia has recurred. 3\. What are the possible complications? The risks of surgery are similar whether the participants join the study or not. Possible complications include: (1) Postoperative pain; (2) Hernia recurrence; (3) Wound infection; (4) Bruising or bleeding under the skin at the needle site This study will help us to determine whether the new needle set could decrease the complication rate. 4\. Participation in this study is completely voluntary. For the patients unwilling to participate this study, they will receive the standard procedures at present, including: (1) Open hernia repair with mesh, Lichtenstein method. (2) Laparoscopic hernia repair with mesh, TEP or TAPP. (3) Laparoscopic repair using the conventional hernia needle
Conditions
- Inguinal Hernia, Without Mention of Obstruction or Gangrene
Interventions
non-mesh inguinal hernia needleDevice
Non-mesh inguinal hernia needle is used for indirect inguinal hernia repair by laparoscopy. It is composed of puncture needle and suture needle.
conventional needle setDevice
Conventional needle set is used traditionally for percutaneous internal ring suture in Chang Gung Memorial Hospital at Chiayi, Taiwan.
Primary outcomes
What the sponsor says the trial is designed to measure.
- post operational painTime frame: From enrollment to the end of treatment at 24 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Chang Gung Memorial Hospital
Chiayi City, Taiwan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.